Advertisement

Index by Author

June 1998; 47 (6)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Almind, K

    • Insulin receptor substrate-2 amino acid polymorphisms are not associated with random type 2 diabetes among Caucasians. Diabetes June 1998 47:976-979; doi:10.2337/diabetes.47.6.976

  2. Antonellis, A

    • Exclusion of the hepatocyte nuclear factor 4alpha as a candidate gene for late-onset NIDDM linked with chromosome 20q. Diabetes June 1998 47:970-972; doi:10.2337/diabetes.47.6.970

  3. Archer, D B

    • Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products. Diabetes June 1998 47:945-952; doi:10.2337/diabetes.47.6.945

  4. Arner, P

    • Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes June 1998 47:913-917; doi:10.2337/diabetes.47.6.913

  5. Ayoub, M

    • Insulin receptor substrate-2 amino acid polymorphisms are not associated with random type 2 diabetes among Caucasians. Diabetes June 1998 47:976-979; doi:10.2337/diabetes.47.6.976

B

  1. Baier, L J

    • Variant in the regulatory subunit of phosphatidylinositol 3-kinase (p85alpha): preliminary evidence indicates a potential role of this variant in the acute insulin response and type 2 diabetes in Pima women. Diabetes June 1998 47:973-975; doi:10.2337/diabetes.47.6.973

  2. Behn, P S

    • Hepatocyte nuclear factor 1alpha coding mutations are an uncommon contributor to early-onset type 2 diabetes in Ashkenazi Jews. Diabetes June 1998 47:967-969; doi:10.2337/diabetes.47.6.967

  3. Bergeron, J

    • Postprandial triglyceride response in visceral obesity in men. Diabetes June 1998 47:953-960; doi:10.2337/diabetes.47.6.953

  4. Bergeron, N

    • Postprandial triglyceride response in visceral obesity in men. Diabetes June 1998 47:953-960; doi:10.2337/diabetes.47.6.953

  5. Bernal, D

    • Insulin receptor substrate-2 amino acid polymorphisms are not associated with random type 2 diabetes among Caucasians. Diabetes June 1998 47:976-979; doi:10.2337/diabetes.47.6.976

  6. Bogardus, C

    • Variant in the regulatory subunit of phosphatidylinositol 3-kinase (p85alpha): preliminary evidence indicates a potential role of this variant in the acute insulin response and type 2 diabetes in Pima women. Diabetes June 1998 47:973-975; doi:10.2337/diabetes.47.6.973

  7. Bouchard, C

    • Postprandial triglyceride response in visceral obesity in men. Diabetes June 1998 47:953-960; doi:10.2337/diabetes.47.6.953

  8. Bruni, N

    • Development and regulation of glucose-6-phosphatase gene expression in rat liver, intestine, and kidney: in vivo and in vitro studies in cultured fetal hepatocytes. Diabetes June 1998 47:882-889; doi:10.2337/diabetes.47.6.882

C

  1. Calcutt, N A

    • Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice. Diabetes June 1998 47:961-966; doi:10.2337/diabetes.47.6.961

  2. Casey, P

    • Exclusion of the hepatocyte nuclear factor 4alpha as a candidate gene for late-onset NIDDM linked with chromosome 20q. Diabetes June 1998 47:970-972; doi:10.2337/diabetes.47.6.970

  3. Chakravarthy, U

    • Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products. Diabetes June 1998 47:945-952; doi:10.2337/diabetes.47.6.945

  4. Chatelain, F

    • Development and regulation of glucose-6-phosphatase gene expression in rat liver, intestine, and kidney: in vivo and in vitro studies in cultured fetal hepatocytes. Diabetes June 1998 47:882-889; doi:10.2337/diabetes.47.6.882

  5. Chayen, S

    • Hepatocyte nuclear factor 1alpha coding mutations are an uncommon contributor to early-onset type 2 diabetes in Ashkenazi Jews. Diabetes June 1998 47:967-969; doi:10.2337/diabetes.47.6.967

  6. Chen, P Y

    • Glucose-6-phosphate and Ca2+ sequestration are mutually enhanced in microsomes from liver, brain, and heart. Diabetes June 1998 47:874-881; doi:10.2337/diabetes.47.6.874

  7. Cherrington, A D

    • Small amounts of fructose markedly augment net hepatic glucose uptake in the conscious dog. Diabetes June 1998 47:867-873; doi:10.2337/diabetes.47.6.867

  8. Chung, S K

    • Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice. Diabetes June 1998 47:961-966; doi:10.2337/diabetes.47.6.961

  9. Chung, S S

    • Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice. Diabetes June 1998 47:961-966; doi:10.2337/diabetes.47.6.961

  10. Couillard, C

    • Postprandial triglyceride response in visceral obesity in men. Diabetes June 1998 47:953-960; doi:10.2337/diabetes.47.6.953

  11. Crijns, F R

    • Arteriolar reactivity in conscious diabetic rats: influence of aminoguanidine treatment. Diabetes June 1998 47:918-923; doi:10.2337/diabetes.47.6.918

  12. Csutora, P

    • Glucose-6-phosphate and Ca2+ sequestration are mutually enhanced in microsomes from liver, brain, and heart. Diabetes June 1998 47:874-881; doi:10.2337/diabetes.47.6.874

D

  1. Dallas-Yang, Q

    • MODY1 mutation Q268X in hepatocyte nuclear factor 4alpha allows for dimerization in solution but causes abnormal subcellular localization. Diabetes June 1998 47:985-990; doi:10.2337/diabetes.47.6.985

  2. Després, J P

    • Postprandial triglyceride response in visceral obesity in men. Diabetes June 1998 47:953-960; doi:10.2337/diabetes.47.6.953

E

  1. Eriksson, P

    • Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes June 1998 47:913-917; doi:10.2337/diabetes.47.6.913

F

  1. Flyvbjerg, A

    • Octreotide prevents the early increase in renal insulin-like growth factor binding protein 1 in streptozotocin diabetic rats. Diabetes June 1998 47:924-930; doi:10.2337/diabetes.47.6.924

G

  1. Galassetti, P

    • Small amounts of fructose markedly augment net hepatic glucose uptake in the conscious dog. Diabetes June 1998 47:867-873; doi:10.2337/diabetes.47.6.867

  2. Giani, G

    • The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group. Diabetes June 1998 47:980-984; doi:10.2337/diabetes.47.6.980

  3. Girard, J

    • Development and regulation of glucose-6-phosphatase gene expression in rat liver, intestine, and kidney: in vivo and in vitro studies in cultured fetal hepatocytes. Diabetes June 1998 47:882-889; doi:10.2337/diabetes.47.6.882

  4. Glaser, B

    • Hepatocyte nuclear factor 1alpha coding mutations are an uncommon contributor to early-onset type 2 diabetes in Ashkenazi Jews. Diabetes June 1998 47:967-969; doi:10.2337/diabetes.47.6.967

  5. Gopalakrishnan, V

    • Insulin increases endothelin-1-evoked intracellular free calcium responses by increased ET(A) receptor expression in rat aortic smooth muscle cells. Diabetes June 1998 47:937-944; doi:10.2337/diabetes.47.6.937

  6. Grønbaek, H

    • Octreotide prevents the early increase in renal insulin-like growth factor binding protein 1 in streptozotocin diabetic rats. Diabetes June 1998 47:924-930; doi:10.2337/diabetes.47.6.924

H

  1. Haastert, B

    • The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group. Diabetes June 1998 47:980-984; doi:10.2337/diabetes.47.6.980

  2. Hanson, R L

    • Variant in the regulatory subunit of phosphatidylinositol 3-kinase (p85alpha): preliminary evidence indicates a potential role of this variant in the acute insulin response and type 2 diabetes in Pima women. Diabetes June 1998 47:973-975; doi:10.2337/diabetes.47.6.973

  3. Harmon, J S

    • Reconstitution of glucotoxic HIT-T15 cells with somatostatin transcription factor-1 partially restores insulin promoter activity. Diabetes June 1998 47:900-904; doi:10.2337/diabetes.47.6.900

  4. Hasnadka, R V

    • Insulin increases endothelin-1-evoked intracellular free calcium responses by increased ET(A) receptor expression in rat aortic smooth muscle cells. Diabetes June 1998 47:937-944; doi:10.2337/diabetes.47.6.937

  5. Hayes, R G

    • Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products. Diabetes June 1998 47:945-952; doi:10.2337/diabetes.47.6.945

  6. Heinze, E

    • The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group. Diabetes June 1998 47:980-984; doi:10.2337/diabetes.47.6.980

  7. Hoffstedt, J

    • Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes June 1998 47:913-917; doi:10.2337/diabetes.47.6.913

  8. Hopfner, R L

    • Insulin increases endothelin-1-evoked intracellular free calcium responses by increased ET(A) receptor expression in rat aortic smooth muscle cells. Diabetes June 1998 47:937-944; doi:10.2337/diabetes.47.6.937

I

  1. Inoguchi, T

    • High glucose induces alteration of gap junction permeability and phosphorylation of connexin-43 in cultured aortic smooth muscle cells. Diabetes June 1998 47:931-936; doi:10.2337/diabetes.47.6.931

J

  1. Ji, L

    • Exclusion of the hepatocyte nuclear factor 4alpha as a candidate gene for late-onset NIDDM linked with chromosome 20q. Diabetes June 1998 47:970-972; doi:10.2337/diabetes.47.6.970

K

  1. King, G L

    • Protein kinase C activation and the development of diabetic complications. Diabetes June 1998 47:859-866; doi:10.2337/diabetes.47.6.859

  2. Klinghammer, A

    • The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group. Diabetes June 1998 47:980-984; doi:10.2337/diabetes.47.6.980

  3. Kolb, H

    • The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group. Diabetes June 1998 47:980-984; doi:10.2337/diabetes.47.6.980

  4. Koya, D

    • Protein kinase C activation and the development of diabetic complications. Diabetes June 1998 47:859-866; doi:10.2337/diabetes.47.6.859

  5. Krolewski, A S

    • Exclusion of the hepatocyte nuclear factor 4alpha as a candidate gene for late-onset NIDDM linked with chromosome 20q. Diabetes June 1998 47:970-972; doi:10.2337/diabetes.47.6.970

  6. Kuroki, T

    • High glucose induces alteration of gap junction permeability and phosphorylation of connexin-43 in cultured aortic smooth muscle cells. Diabetes June 1998 47:931-936; doi:10.2337/diabetes.47.6.931

L

  1. Lampeter, E F

    • The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group. Diabetes June 1998 47:980-984; doi:10.2337/diabetes.47.6.980

  2. Larsson, C

    • Insulin receptor substrate-2 amino acid polymorphisms are not associated with random type 2 diabetes among Caucasians. Diabetes June 1998 47:976-979; doi:10.2337/diabetes.47.6.976

  3. Lee, A Y

    • Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice. Diabetes June 1998 47:961-966; doi:10.2337/diabetes.47.6.961

  4. Lee, F K

    • Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice. Diabetes June 1998 47:961-966; doi:10.2337/diabetes.47.6.961

  5. Lee, L W

    • Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice. Diabetes June 1998 47:961-966; doi:10.2337/diabetes.47.6.961

  6. Liblau, P

    • Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice. Diabetes June 1998 47:894-899; doi:10.2337/diabetes.47.6.894

  7. Liblau, R S

    • Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice. Diabetes June 1998 47:894-899; doi:10.2337/diabetes.47.6.894

  8. Lönnqvist, F

    • Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes June 1998 47:913-917; doi:10.2337/diabetes.47.6.913

M

  1. Malecki, M T

    • Exclusion of the hepatocyte nuclear factor 4alpha as a candidate gene for late-onset NIDDM linked with chromosome 20q. Diabetes June 1998 47:970-972; doi:10.2337/diabetes.47.6.970

  2. Marchase, R B

    • Glucose-6-phosphate and Ca2+ sequestration are mutually enhanced in microsomes from liver, brain, and heart. Diabetes June 1998 47:874-881; doi:10.2337/diabetes.47.6.874

  3. Mauriège, P

    • Postprandial triglyceride response in visceral obesity in men. Diabetes June 1998 47:953-960; doi:10.2337/diabetes.47.6.953

  4. McAuley, E

    • Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products. Diabetes June 1998 47:945-952; doi:10.2337/diabetes.47.6.945

  5. McDevitt, H O

    • Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice. Diabetes June 1998 47:894-899; doi:10.2337/diabetes.47.6.894

  6. McNeill, J R

    • Insulin increases endothelin-1-evoked intracellular free calcium responses by increased ET(A) receptor expression in rat aortic smooth muscle cells. Diabetes June 1998 47:937-944; doi:10.2337/diabetes.47.6.937

  7. Minassian, C

    • Development and regulation of glucose-6-phosphatase gene expression in rat liver, intestine, and kidney: in vivo and in vitro studies in cultured fetal hepatocytes. Diabetes June 1998 47:882-889; doi:10.2337/diabetes.47.6.882

  8. Mithieux, G

    • Development and regulation of glucose-6-phosphatase gene expression in rat liver, intestine, and kidney: in vivo and in vitro studies in cultured fetal hepatocytes. Diabetes June 1998 47:882-889; doi:10.2337/diabetes.47.6.882

  9. Monohan, M

    • Small amounts of fructose markedly augment net hepatic glucose uptake in the conscious dog. Diabetes June 1998 47:867-873; doi:10.2337/diabetes.47.6.867

  10. Mori, M

    • Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin. Diabetes June 1998 47:890-893; doi:10.2337/diabetes.47.6.890

N

  1. Nawata, H

    • High glucose induces alteration of gap junction permeability and phosphorylation of connexin-43 in cultured aortic smooth muscle cells. Diabetes June 1998 47:931-936; doi:10.2337/diabetes.47.6.931

  2. Neal, D W

    • Small amounts of fructose markedly augment net hepatic glucose uptake in the conscious dog. Diabetes June 1998 47:867-873; doi:10.2337/diabetes.47.6.867

  3. Nepomuceno, L

    • MODY1 mutation Q268X in hepatocyte nuclear factor 4alpha allows for dimerization in solution but causes abnormal subcellular localization. Diabetes June 1998 47:985-990; doi:10.2337/diabetes.47.6.985

  4. Ng, D T

    • Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice. Diabetes June 1998 47:961-966; doi:10.2337/diabetes.47.6.961

  5. Ng, T F

    • Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice. Diabetes June 1998 47:961-966; doi:10.2337/diabetes.47.6.961

O

  1. Ohtani, K

    • Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin. Diabetes June 1998 47:890-893; doi:10.2337/diabetes.47.6.890

  2. Olson, L K

    • Reconstitution of glucotoxic HIT-T15 cells with somatostatin transcription factor-1 partially restores insulin promoter activity. Diabetes June 1998 47:900-904; doi:10.2337/diabetes.47.6.900

P

  1. Pedersen, O

    • Insulin receptor substrate-2 amino acid polymorphisms are not associated with random type 2 diabetes among Caucasians. Diabetes June 1998 47:976-979; doi:10.2337/diabetes.47.6.976

  2. Pégorier, J P

    • Development and regulation of glucose-6-phosphatase gene expression in rat liver, intestine, and kidney: in vivo and in vitro studies in cultured fetal hepatocytes. Diabetes June 1998 47:882-889; doi:10.2337/diabetes.47.6.882

  3. Permutt, M A

    • Hepatocyte nuclear factor 1alpha coding mutations are an uncommon contributor to early-onset type 2 diabetes in Ashkenazi Jews. Diabetes June 1998 47:967-969; doi:10.2337/diabetes.47.6.967

  4. Popovtzer, M

    • Octreotide prevents the early increase in renal insulin-like growth factor binding protein 1 in streptozotocin diabetic rats. Diabetes June 1998 47:924-930; doi:10.2337/diabetes.47.6.924

  5. Prud'homme, D

    • Postprandial triglyceride response in visceral obesity in men. Diabetes June 1998 47:953-960; doi:10.2337/diabetes.47.6.953

R

  1. Raz, I

    • Octreotide prevents the early increase in renal insulin-like growth factor binding protein 1 in streptozotocin diabetic rats. Diabetes June 1998 47:924-930; doi:10.2337/diabetes.47.6.924

  2. Reynisdottir, S

    • Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes June 1998 47:913-917; doi:10.2337/diabetes.47.6.913

  3. Robertson, R P

    • Reconstitution of glucotoxic HIT-T15 cells with somatostatin transcription factor-1 partially restores insulin promoter activity. Diabetes June 1998 47:900-904; doi:10.2337/diabetes.47.6.900

  4. Rosshani, L

    • Insulin receptor substrate-2 amino acid polymorphisms are not associated with random type 2 diabetes among Caucasians. Diabetes June 1998 47:976-979; doi:10.2337/diabetes.47.6.976

  5. Rubinger, D

    • Octreotide prevents the early increase in renal insulin-like growth factor binding protein 1 in streptozotocin diabetic rats. Diabetes June 1998 47:924-930; doi:10.2337/diabetes.47.6.924

S

  1. Sato, N

    • Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin. Diabetes June 1998 47:890-893; doi:10.2337/diabetes.47.6.890

  2. Scherbaum, W A

    • The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group. Diabetes June 1998 47:980-984; doi:10.2337/diabetes.47.6.980

  3. Sharp, G W

    • Atypical protein kinase C isozyme zeta mediates carbachol-stimulated insulin secretion in RINm5F cells. Diabetes June 1998 47:905-912; doi:10.2337/diabetes.47.6.905

  4. Shimizu, H

    • Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin. Diabetes June 1998 47:890-893; doi:10.2337/diabetes.47.6.890

  5. Shiota, M

    • Small amounts of fructose markedly augment net hepatic glucose uptake in the conscious dog. Diabetes June 1998 47:867-873; doi:10.2337/diabetes.47.6.867

  6. Sladek, F M

    • MODY1 mutation Q268X in hepatocyte nuclear factor 4alpha allows for dimerization in solution but causes abnormal subcellular localization. Diabetes June 1998 47:985-990; doi:10.2337/diabetes.47.6.985

  7. Smolovitch, I

    • Hepatocyte nuclear factor 1alpha coding mutations are an uncommon contributor to early-onset type 2 diabetes in Ashkenazi Jews. Diabetes June 1998 47:967-969; doi:10.2337/diabetes.47.6.967

  8. Song, Z T

    • Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice. Diabetes June 1998 47:961-966; doi:10.2337/diabetes.47.6.961

  9. Stitt, A W

    • Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products. Diabetes June 1998 47:945-952; doi:10.2337/diabetes.47.6.945

  10. Struijker Boudier, H A

    • Arteriolar reactivity in conscious diabetic rats: influence of aminoguanidine treatment. Diabetes June 1998 47:918-923; doi:10.2337/diabetes.47.6.918

T

  1. Tanaka, Y

    • Reconstitution of glucotoxic HIT-T15 cells with somatostatin transcription factor-1 partially restores insulin promoter activity. Diabetes June 1998 47:900-904; doi:10.2337/diabetes.47.6.900

  2. Tang, S H

    • Atypical protein kinase C isozyme zeta mediates carbachol-stimulated insulin secretion in RINm5F cells. Diabetes June 1998 47:905-912; doi:10.2337/diabetes.47.6.905

  3. Tarpin, S

    • Development and regulation of glucose-6-phosphatase gene expression in rat liver, intestine, and kidney: in vivo and in vitro studies in cultured fetal hepatocytes. Diabetes June 1998 47:882-889; doi:10.2337/diabetes.47.6.882

  4. Thomas, J

    • Hepatocyte nuclear factor 1alpha coding mutations are an uncommon contributor to early-onset type 2 diabetes in Ashkenazi Jews. Diabetes June 1998 47:967-969; doi:10.2337/diabetes.47.6.967

  5. Thörne, A

    • Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes June 1998 47:913-917; doi:10.2337/diabetes.47.6.913

  6. Tisch, R

    • Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice. Diabetes June 1998 47:894-899; doi:10.2337/diabetes.47.6.894

  7. Tremblay, A

    • Postprandial triglyceride response in visceral obesity in men. Diabetes June 1998 47:953-960; doi:10.2337/diabetes.47.6.953

U

  1. Ueda, F

    • High glucose induces alteration of gap junction permeability and phosphorylation of connexin-43 in cultured aortic smooth muscle cells. Diabetes June 1998 47:931-936; doi:10.2337/diabetes.47.6.931

  2. Uehara, Y

    • Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin. Diabetes June 1998 47:890-893; doi:10.2337/diabetes.47.6.890

  3. Umeda, F

    • High glucose induces alteration of gap junction permeability and phosphorylation of connexin-43 in cultured aortic smooth muscle cells. Diabetes June 1998 47:931-936; doi:10.2337/diabetes.47.6.931

V

  1. Van Harmelen, V

    • Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes June 1998 47:913-917; doi:10.2337/diabetes.47.6.913

  2. Veyna-Burke, N A

    • Glucose-6-phosphate and Ca2+ sequestration are mutually enhanced in microsomes from liver, brain, and heart. Diabetes June 1998 47:874-881; doi:10.2337/diabetes.47.6.874

W

  1. Wantman, M

    • Exclusion of the hepatocyte nuclear factor 4alpha as a candidate gene for late-onset NIDDM linked with chromosome 20q. Diabetes June 1998 47:970-972; doi:10.2337/diabetes.47.6.970

  2. Warram, J H

    • Exclusion of the hepatocyte nuclear factor 4alpha as a candidate gene for late-onset NIDDM linked with chromosome 20q. Diabetes June 1998 47:970-972; doi:10.2337/diabetes.47.6.970

  3. Wasson, J

    • Hepatocyte nuclear factor 1alpha coding mutations are an uncommon contributor to early-onset type 2 diabetes in Ashkenazi Jews. Diabetes June 1998 47:967-969; doi:10.2337/diabetes.47.6.967

  4. Weiss, O

    • Octreotide prevents the early increase in renal insulin-like growth factor binding protein 1 in streptozotocin diabetic rats. Diabetes June 1998 47:924-930; doi:10.2337/diabetes.47.6.924

  5. White, M F

    • Insulin receptor substrate-2 amino acid polymorphisms are not associated with random type 2 diabetes among Caucasians. Diabetes June 1998 47:976-979; doi:10.2337/diabetes.47.6.976

  6. Wiedrich, C

    • Variant in the regulatory subunit of phosphatidylinositol 3-kinase (p85alpha): preliminary evidence indicates a potential role of this variant in the acute insulin response and type 2 diabetes in Pima women. Diabetes June 1998 47:973-975; doi:10.2337/diabetes.47.6.973

  7. Wilson, T W

    • Insulin increases endothelin-1-evoked intracellular free calcium responses by increased ET(A) receptor expression in rat aortic smooth muscle cells. Diabetes June 1998 47:937-944; doi:10.2337/diabetes.47.6.937

  8. Wolffenbuttel, B H

    • Arteriolar reactivity in conscious diabetic rats: influence of aminoguanidine treatment. Diabetes June 1998 47:918-923; doi:10.2337/diabetes.47.6.918

Y

  1. Yang, X D

    • Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice. Diabetes June 1998 47:894-899; doi:10.2337/diabetes.47.6.894

  2. Yenush, L

    • Insulin receptor substrate-2 amino acid polymorphisms are not associated with random type 2 diabetes among Caucasians. Diabetes June 1998 47:976-979; doi:10.2337/diabetes.47.6.976

Z

  1. Zhang, Y

    • Insulin receptor substrate-2 amino acid polymorphisms are not associated with random type 2 diabetes among Caucasians. Diabetes June 1998 47:976-979; doi:10.2337/diabetes.47.6.976

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement